Company: IONQ
Filing Date: 2025-10-17
Form Type: 424B7
Source: 0000950142-25-002826
Chunk: 10

Company: IonQ, Inc.
Filing Date: 2025-10-17
Form: 424B7
Chunk 10
---
holders pursuant to this prospectus supplement and that the selling 
 stockholders buy or sell no additional shares of our common stock prior to the completion of the offering.                            |

| S-8 |

| (3) | Consists of shares of common stock held by Atmos Ventures ASI SKA. The business address for the selling stockholder is Aleje Jerozolimskie 
 181B, 02-222, Warsaw, Poland.                                                                                                              |

| (4) | Consists of shares of common stock held by Braavos Capital II LP. The business address for the selling stockholder is 2nd Floor, Dorey 
 Court, Elizabeth Avenue, St. Peter Port, Guernsey, GY1 2HT.                                                                            |

| (5) | Pursuant to the Share Purchase Agreement, dated June 7, 2025 (the “SPA”), among the Company, Oxford Ionics Limited,                             
 the Sellers (as defined therein), and Oxford Science Enterprises plc, solely in its capacity as the representative of the Sellers, each         
 of Christopher Ballance and Thomas Harty have agreed not to transfer (i) more than 40% of the shares of common stock issued to such stockholder 
 pursuant to the SPA prior to the one-year anniversary of such issuance, (ii) more than 52% of the shares of common stock issued to such         
 stockholder pursuant to the SPA prior to the two-year anniversary of such issuance, (iii) more than 64% of the shares of common stock           
 issued to such stockholder pursuant to the SPA prior to the three-year anniversary of such issuance, (iv) more than 76% of the shares           
 of common stock issued to such stockholder pursuant to the SPA prior to the four-year anniversary of such issuance and (v) more than 88%        
 of the shares of common stock issued to such stockholder pursuant to the SPA prior to the five-year anniversary of such issuance, in each       
 case subject to certain exceptions. The address for the selling stockholder is 46 Woodstock Road, Oxford, OX2 6HT, United Kingdom.              |

| (6) | Consists of shares of common stock held by Lansdowne Developed Markets Master Fund Limited. The business address of the selling stockholder 
 is PO Box 309, Ugland House, Grand Cayman KY1-1104, Cayman Islands.                                                                         |

| (7) | Consists of shares of common stock held by Naspers